Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Veracyte, Inc. (VCYT)  
$20.12 0.91 (4.33%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,823,000
Market Cap: 1.67(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.92 - $29.92
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  484
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 60,000
Total Buy Value $0 $0 $0 $980,094
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 20,000 20,000 104,169 535,146
Total Sell Value $460,127 $460,127 $2,968,197 $14,025,264
Total People Sold 2 2 4 8
Total Sell Transactions 2 2 12 30
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 524
  Page 4 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Anderson Bonnie H Director   –       •      –    2023-01-11 4 OE $14.34 $906,962 D/D 63,247 126,208     -
   Jones Evan/ Fa Director   –       •      –    2022-12-14 4 AS $30.13 $18,080 D/D (600) 50,184 -25%     
   Jones Evan/ Fa Director   –       •      –    2022-12-13 4 AS $30.51 $51,197 D/D (1,667) 50,784 -26%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-12-06 4 AS $27.03 $27,652 D/D (1,023) 65,970 -16%     
   Stapley Marc Chief Executive Officer   •       •      –    2022-12-02 4 D $29.14 $29,490 D/D (1,012) 158,299     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-12-02 4 D $29.14 $59,504 D/D (2,042) 62,961     -
   Chambers Rebecca Chief Financial Officer   •       –      –    2022-12-02 4 D $29.14 $21,418 D/D (735) 72,998     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-12-02 4 D $29.14 $29,373 D/D (1,008) 66,993     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-12-01 4 AS $27.81 $2,260,748 D/D (80,000) 65,003 -21%     
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-12-01 4 OE $5.61 $885,300 D/D 80,000 145,003     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-11-11 4 AS $29.34 $59 D/D (2) 68,001 -27%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-11-11 4 OE $14.34 $29 D/D 2 68,003     -
   Jones Evan/ Fa Director   –       •      –    2022-11-11 4 AS $30.21 $181,357 D/D (6,000) 52,451 -27%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-11-04 4 AS $25.00 $25,575 D/D (1,023) 68,001 -8%     
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-10-13 4 OE $8.86 $99,996 D/D 11,088 76,091     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-09-02 4 D $19.18 $19,333 D/D (1,008) 69,024     -
   Chambers Rebecca Chief Financial Officer   •       –      –    2022-09-02 4 D $19.18 $57,981 D/D (3,023) 73,733     -
   Stapley Marc Chief Executive Officer   •       •      –    2022-09-02 4 D $19.18 $19,410 D/D (1,012) 159,311     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-09-02 4 D $19.18 $39,166 D/D (2,042) 65,003     -
   Barr Eliav Director   –       •      –    2022-08-09 4 A $0.00 $0 D/D 20,721 20,721     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-08-08 4 S $27.24 $1,229,075 I/I (45,000) 112,426 1%     
   Chambers Rebecca Chief Financial Officer   •       –      –    2022-08-05 4 A $0.00 $0 D/D 21,404 76,756     -
   Mcguire Annie SVP, General Counsel   •       –      –    2022-08-05 4 A $0.00 $0 D/D 10,702 33,557     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-08-05 4 S $27.71 $2,131,370 I/I (76,917) 157,426 2%     
   Wygant Jonathan VP, Chief Accounting Officer   •       –      –    2022-08-05 4 A $0.00 $0 D/D 8,561 20,561     -
  524 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us